These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19156522)

  • 1. Liver transplantation for hepatocellular carcinoma in the MELD era: leading roles of MELD score, AFP level, and recipient age as predictors of survival.
    Sotiropoulos GC; Molmenti EP; Lang H
    Dig Dis Sci; 2009 Apr; 54(4):917. PubMed ID: 19156522
    [No Abstract]   [Full Text] [Related]  

  • 2. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.
    Yaprak O; Akyildiz M; Dayangac M; Demirbas BT; Guler N; Dogusoy GB; Yuzer Y; Tokat Y
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):256-61. PubMed ID: 22672818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downstaging of hepatocellular carcinoma before transplantation: an advance in therapy or just another selection criterion.
    Lo C
    Am J Transplant; 2008 Dec; 8(12):2485-6. PubMed ID: 19032218
    [No Abstract]   [Full Text] [Related]  

  • 4. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation.
    De Carlis L; Giacomoni A; Pirotta V; Lauterio A; Slim AO; Sammartino C; Cardillo M; Forti D
    J Am Coll Surg; 2003 Jun; 196(6):887-97. PubMed ID: 12788425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.
    Mazzaferro V; Sposito C; Zhou J; Pinna AD; De Carlis L; Fan J; Cescon M; Di Sandro S; Yi-Feng H; Lauterio A; Bongini M; Cucchetti A
    Gastroenterology; 2018 Jan; 154(1):128-139. PubMed ID: 28989060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil.
    Freitas AC; Itikawa WM; Kurogi AS; Stadnik LG; Parolin MB; Coelho JC
    Arq Gastroenterol; 2010; 47(3):233-7. PubMed ID: 21140081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocellular carcinoma: impact of waiting list and pre-operative treatment strategies on survival of cadaveric liver transplantation in pre-MELD era in one center in Brazil].
    Freitas AC; Parolin MB; Stadnik L; Coelho JC
    Arq Gastroenterol; 2007; 44(3):189-94. PubMed ID: 18060269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma.
    Schraiber LDS; de Mattos AA; Zanotelli ML; Cantisani GPC; Brandão ABM; Marroni CA; Kiss G; Ernani L; Marcon PDS
    Medicine (Baltimore); 2016 Jan; 95(3):e2478. PubMed ID: 26817881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When to call it off: defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma.
    Bhatti ABH; Qureshi AI; Tahir R; Dar FS; Khan NY; Zia HH; Riyaz S; Rana A
    BMC Cancer; 2020 Aug; 20(1):754. PubMed ID: 32787864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AFP in OLT for HCC?: Another shadow on the cave wall: Comment on "Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer".
    Cameron AM
    Arch Surg; 2011 Jan; 146(1):33-4. PubMed ID: 21305708
    [No Abstract]   [Full Text] [Related]  

  • 12. AGMA Score: A Novel Prognostic Score for Patients Undergoing Liver Transplant for Hepatocellular Carcinoma.
    Sotiropoulos GC; Malago M; Machairas N; Fouzas I; Paul A
    Transplant Proc; 2019; 51(6):1923-1925. PubMed ID: 31399177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer.
    Grąt M; Stypułkowski J; Patkowski W; Wronka KM; Bik E; Krasnodębski M; Masior Ł; Lewandowski Z; Wasilewicz M; Grąt K; Krawczyk M; Zieniewicz K
    Ann Surg Oncol; 2017 Oct; 24(11):3188-3195. PubMed ID: 28695391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological differentiation predicts post-liver transplantation survival time.
    Li WX; Li Z; Gao PJ; Gao J; Zhu JY
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):201-8. PubMed ID: 24388339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.
    Mahmud N; John B; Taddei TH; Goldberg DS
    Clin Transplant; 2019 Jul; 33(7):e13634. PubMed ID: 31177570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
    Kornberg A; Schernhammer M; Kornberg J; Friess H; Thrum K
    Dig Dis Sci; 2019 Jan; 64(1):269-280. PubMed ID: 30259282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
    Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN
    Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Importance of AFP in Liver Transplantation for HCC.
    Özdemir F; Baskiran A
    J Gastrointest Cancer; 2020 Dec; 51(4):1127-1132. PubMed ID: 32845425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer.
    Mailey B; Artinyan A; Khalili J; Denitz J; Sanchez-Luege N; Sun CL; Bhatia S; Nissen N; Colquhoun SD; Kim J
    Arch Surg; 2011 Jan; 146(1):26-33. PubMed ID: 21242442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.